|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
| (51) | INT.CL. | C12N 5/06 | |
| C07K 16/28 | |||
| A61K 39/395 | |||
| C12N 15/13 |
| (11) | Patento numeris | 1478738 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 03713632.2 |
| Europos patento paraiškos padavimo data | 2003-02-21 | |
| (97) | Europos patento paraiškos paskelbimo data | 2004-11-24 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2008-11-12 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2003/005500 |
| Data | 2003-02-21 |
| (87) | Numeris | WO 2003/072766 |
| Data | 2003-09-04 |
| (30) | Numeris | Data | Šalis |
| 81128 | 2002-02-22 | US |
| (72) |
OLSON, William, C., US
MADDON, Paul. J., US
VASQUEZ, Maximiliano, US
HINTON, Paul, R., US
TSURUSHITA, Naoya, US
|
| (73) |
PROGENICS PHARMACEUTICALS, INC.,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
PDL BioPharma, Inc., 1400 Seaport Blvd., Redwood City, CA 94063, US |
| (54) | ANTI-CCR5 ANTIBODY |
| ANTI-CCR5 ANTIBODY |